NCT06911099 Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
| NCT ID | NCT06911099 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Cologne |
| Condition | Atrial Functional Mitral Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2010-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2010-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.
Eligibility Criteria
Inclusion Criteria: * functional mitral regurgitation * left ventricular ejection fraction ≥50% Exclusion Criteria: * age under 18 years * known regional wall movement disorders
Contact & Investigator
Christos Iliadis, MD
PRINCIPAL INVESTIGATOR
Heart Center, Department III of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany
Frequently Asked Questions
Who can join the NCT06911099 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Functional Mitral Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06911099 currently recruiting?
Yes, NCT06911099 is actively recruiting participants. Contact the research team at philipp.von-stein@uk-koeln.de for enrollment information.
Where is the NCT06911099 trial being conducted?
This trial is being conducted at The Bronx, United States, Toronto, Canada, Bordeaux, France, Nantes, France and 11 additional locations.
Who is sponsoring the NCT06911099 clinical trial?
NCT06911099 is sponsored by University Hospital of Cologne. The principal investigator is Christos Iliadis, MD at Heart Center, Department III of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany. The trial plans to enroll 1,000 participants.